secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2024-06-06T23:59:59+00:00
Accession:  0001759425-24-000023
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Stockholders elect all three Class II directors, ratify auditor, approve say-on-pay, set frequency to one year
--------------------------------------------------------------------------------

- Elected Laurent Fischer, Patrick Heron, and Saira Ramasastry as Class II directors (each received >19M votes for).
- Ratified Ernst & Young as independent auditor for FY2024 (37.5M for, 36k against, 143k abstain).
- Advisory approval of executive compensation: 32.7M for, 1.1M against, 90k abstain.
- Advisory vote on say-on-pay frequency: 33.8M for one year; board adopts annual frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000175942524000023/0001759425-24-000023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000175942524000023/mirm-20240605.htm
  HTML page:      https://secwatch.observer/filing/0001759425-24-000023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer